El Ain Palace invests 3.75 million pounds to launch targeted molecular diagnostics, entering the era of precision medicine

Al-Qasr Al-Aini College of Medicine at Cairo University is planning to adopt targeted molecular diagnosis (precision medicine) using the Idylla device, which cost 3.75 million Egyptian pounds, to enhance its capabilities in clinical diagnostics. This device allows for rapid and accurate molecular testing, with results produced within two and a half to three hours, contributing to improved selection of targeted treatments for tumors and other diseases. The initiative focuses on developing the diagnostic system and scientific research, aiming to position the college as a reference center for molecular diagnostic services both within Egypt and internationally, while strengthening its status as a leading institution in precision medicine.